NFKB1 and glioblastoma: Aberrant NF-κB activation has been well-known in GBM and other malignant tumors; and activation of NF-κB can promote proliferation, survival, angiogenesis, metastasis, and invasion of tumor cells, contributing to tumor promotion and progression [21–23].